Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial

Simon Lebech Cichosz, Lars Holger Ehlers, Ole Hejlesen, Simon Lebech Cichosz, Lars Holger Ehlers, Ole Hejlesen

Abstract

Background: Several heart failure studies have shown promising results for implementing telehealthcare. These studies have led to clinical and political interest in telehealthcare as a way to improve heart failure outcomes and lower costs. However, there is a need for large-scale clinical trials with cost-effectiveness assessments.

Methods/design: The present study is known as the TeleCare North Heart Failure Trial in Denmark. We are studying the health effectiveness and cost-effectiveness of a telehealth (Telekit) solution compared with usual care for patients with heart failure. The design is a multicenter, two-arm, parallel-group, nonblinded, superiority randomized controlled trial. Outpatient healthcare centers will be responsible for recruiting eligible participants (600 participants are expected) for the trial in the geographic area of the North Denmark Region. Participants are qualified for inclusion if they have been diagnosed according to national guidelines and are categorized in New York Heart Association class 2, 3, or 4. Patients must have a permanent residence and be motivated to use telehealth care. The primary outcomes are changes in health-related quality of life (assessed using the Kansas City Cardiomyopathy Questionnaire, the EuroQol EQ-5D-5L questionnaire, and the Short Form Health Survey [SF-36]) and in the incremental cost-effectiveness ratio measured from baseline to follow-up. The secondary outcomes are changes in mortality and in physiological indicators such as blood pressure, pulse, and weight.

Discussion: The TeleCare North Heart Failure Trial is intended to improve the international evidence base for the health effectiveness and cost-effectiveness of telehealthcare for patients with heart failure. The expectation is that the results of the trial can be generalized to all municipalities in Denmark and serve as an inspiration for further international research.

Trial registration: ClinicalTrials.gov ( NCT02860013 ). Registered on 28 July 2016.

Keywords: Cost-effectiveness; Denmark; Effectiveness; Heart failure; Randomized trial; Telemedicine.

Figures

Fig. 1
Fig. 1
Flow diagram for inclusion, treatment, and follow-up

References

    1. Ponikowski P, Anker SD, Al-Habib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: preventing disease and death worldwide. Sophia Antipolis, France: European Society of Cardiology; 2014.
    1. Krum H, Abraham WT. Heart failure. Lancet. 2009;373:941–55. doi: 10.1016/S0140-6736(09)60236-1.
    1. Bui AL, Horwish TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8:30–41. doi: 10.1038/nrcardio.2010.165.
    1. Blair JE, Huffman M, Shah SJ. Heart failure in North America. Curr Cardiol Rev. 2013;9:128–46. doi: 10.2174/1573403X11309020006.
    1. Guo Y, Lip GY, Banerjee A. Heart failure in East Asia. Curr Cardiol Rev. 2013;9:112–22. doi: 10.2174/1573403X11309020004.
    1. Al-Shamiri M. Heart failure in the Middle East. Curr Cardiol Rev. 2013;9:174–8. doi: 10.2174/1573403X11309020009.
    1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–44. doi: 10.1161/CIR.0b013e31820a55f5.
    1. Hjertesvigt KJ. ; 2015. .
    1. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, et al. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare. 2010;16:120–7. doi: 10.1258/jtt.2009.090812.
    1. de Toledo P, Jiménez S, del Pozo F, Roca J, Alonso A, Hernandez C. Telemedicine experience for chronic care in COPD. IEEE Trans Inf Technol Biomed. 2006;10:567–73. doi: 10.1109/TITB.2005.863877.
    1. Haesum LKE, Soerensen N, Dinesen B, Nielsen C, Grann O, Hejlesen O, et al. Cost-utility analysis of a telerehabilitation program: a case study of COPD patients. Telemed J E Health. 2012;18:688–92. doi: 10.1089/tmj.2011.0250.
    1. Johnston B, Wheeler L, Deuser J, Sousa KH. Outcomes of the Kaiser Permanente Tele-Home Health Research Project. Arch Fam Med. 2000;9:40–5. doi: 10.1001/archfami.9.1.40.
    1. Paré G, Poba-Nzaou P, Sicotte C, Beaupré A, Lefrançois É, Nault D, et al. Comparing the costs of home telemonitoring and usual care of chronic obstructive pulmonary disease patients: a randomized controlled trial. Eur Res Telemed. 2013;2:35–47. doi: 10.1016/j.eurtel.2013.05.001.
    1. Louise AA, Tuner T, Gretton M, Baksh A, Cleland JG. A systematic review of telemonitoring for the management of heart failure. Eur J Heart Fail. 2003;5:583–90. doi: 10.1016/S1388-9842(03)00160-0.
    1. Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet. 2011;378:731–9. doi: 10.1016/S0140-6736(11)61229-4.
    1. Chaudhry SI, Mattera JA, Curtis JP, Spertua JA, Herrin J, Lin Z, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363:2301–9. doi: 10.1056/NEJMoa1010029.
    1. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the Telemedical Interventional Monitoring in Heart Failure Study. Circulation. 2011;123:1873–80. doi: 10.1161/CIRCULATIONAHA.111.018473.
    1. Udsen FW, Lilholt PH, Hejlesen O, Ehlers LH. Effectiveness and cost-effectiveness of telehealthcare for chronic obstructive pulmonary disease: study protocol for a cluster randomized controlled trial. Trials. 2014;15:178. doi: 10.1186/1745-6215-15-178.
    1. Dansk Cardiologisk Selskab. Nationale behandlingsvejledning 2015. Dansk Cardiologisk Selskab; 2015.
    1. Dinesen B, Haesum LKE, Soerensen N, Nielsen C, Grann O, Hejlesen O, et al. Using preventive home monitoring to reduce hospital admission rates and reduce costs: a case study of telehealth among chronic obstructive pulmonary disease patients. J Telemed Telecare. 2012;18:221–5. doi: 10.1258/jtt.2012.110704.
    1. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661. doi: 10.1136/bmj.e5661.
    1. Sterne JC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. doi: 10.1136/bmj.b2393.
    1. Wittrup-Jensen K. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health. 2009;37:459–66. doi: 10.1177/1403494809105287.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj